Catalyst Pharmaceuticals
CPRX
$16.66
Share price
1.03%
Change (1 day)
26.79%
Change (1 year)
Categories
Market capitalization of Catalyst Pharmaceuticals (CPRX)
Market cap: $1.96 Billion
As of May 2024 Catalyst Pharmaceuticals has a market cap of $1.96 Billion. This makes Catalyst Pharmaceuticals the world's 4185th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Catalyst Pharmaceuticals from 2006 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $1.96 B | 9.8% |
| 2023 | $1.79 B | -7.42% |
| 2022 | $1.93 B | 177.62% |
| 2021 | $0.69 B | 101.15% |
| 2020 | $0.34 B | -10.6% |
| 2019 | $0.38 B | 96.56% |
| 2018 | $0.19 B | -50.77% |
| 2017 | $0.40 B | 360.32% |
| 2016 | $87.04 M | -57.12% |
| 2015 | $0.20 B | -1.12% |
| 2014 | $0.20 B | 94.47% |
| 2013 | $0.10 B | 485.85% |
| 2012 | $18.01 M | -43.45% |
| 2011 | $31.86 M | 65.96% |
| 2010 | $19.2 M | 68.96% |
| 2009 | $11.36 M | -55.1% |
| 2008 | $25.3 M | -41.44% |
| 2007 | $43.22 M | -28.51% |
| 2006 | $60.45 M |
End of Day market cap according to different sources
On May 15th, 2024 the market cap of Catalyst Pharmaceuticals was reported to be:
$1.96 Billion
$1.96 Billion
$1.96 Billion
$1.96 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $367.42 B | 18,572.05% | 🇺🇸 USA |
 Pfizer PFE | $163.31 B | 8,199.19% | 🇺🇸 USA |
 Abbott Laboratories ABT | $181.94 B | 9,146.28% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $12.52 B | 536.47% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.82 M | -99.96% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $15.26 B | 675.81% | 🇺🇸 USA |